Press Releases

Acroscell Releases Voltage-gated Potassium Channels to Accelerate The Development of Drug Development

Creative Biogene Launches A Large Panel of Genome Editing Services to Accelerate Bioprocess of Drug Development

Microbialtec Established A Mature Platform for Escherichia Coli Cultivation to Accelerate Microbial Isolation and Culture

CD Formulation Offers Customized Synthesis to Meet the Demand for Lipid Excipients

As a New York-based CRO company, CD Formulation has keenly observed that the demand for tailored pharmaceutical excipients is on the rise, especially over the past decade, as each formulation project may need unique excipients. In response to such a market trend, the management of CD Formulation earlier this month announces to offer customized synthesis for lipid excipients, which are used in lipid-based dosage forms for the enhancement of drug absorption or delivery.

Nanomaterial News Update: Alfa Chemistry Upgrades Its Nanoprism Product Line

Medix Biochemica announces the launch of its refreshed, and expanding, brand

Medix Biochemica has announced the launch of its refreshed and expanding brand to reflect both the exciting improvements to its offering as a result of recent acquisitions and its ongoing commitment to the in vitro diagnostics (IVD) industry.

World's first Microhub makes spatial context accessible for all

Leica Microsystems has announced a new Mica imaging platform bringing previously inaccessible experiments to all life science researchers.

WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at its Wuxi City Site

Lonza Leads Market with Large and HLA-Typed CD34+ Cell Lots for Efficient Humanized Mouse Model Development

Lonza has expanded its renowned human stem cell offerings to provide human cord blood CD34+ hematopoietic stem cells (CB-CD34+ HSCs) in large batch sizes, meeting a critical and rapidly expanding market need

UK Regulator Cites CluePoints’ Solutions in Updated Guidance

UK Regulator Cites CluePoints’ Solutions in Updated Guidance MHRA shares CluePoints case study to demonstrate the value of statistical monitoring in clinical trial oversight and monitoring King of Prussia, PA – 7th March 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has been cited in the updated Good Clinical Practice (GCP) guidance from the UK’s MHRA, putting the agency´s considerable weight behind CluePoints’ industry-leading statistical monitoring solutions.

Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles

Australian clinical-stage drug development company Noxopharm (ASX:NOX) has announced its Phase 1 CEP-2 sarcoma trial is underway with a first patient enrolled and dosed at City of Hope in Los Angeles, California.

FDB to Turn ‘What If’ into ‘What Is’ with Industry-Changing Announcement at HIMSS22

First Databank makes industry-changing announcement at HIMSS22

Alfa Chemistry Announces Completion of Building a Sub-website for Polymer Stabilizers

Aragen acquires Intox Pvt. Ltd

Molecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions

Molecular Health has collaborated to announce the publication of a triad of articles that demonstrates the concept of a novel systems approach to elucidate the molecular mechanisms of drug toxicities using real-world data (RWD).

Emmes Acquires Casimir, Its Fourth Major Acquisition

Japan tops CPhI ‘API Quality’ ranking for second year

CD Formulation Announces Ability to Achieve Solubility Improvement and Bioavailability Enhancement for Drug Formulation Projects

IonsGate Preclinical Services and InSilicoTrials together to innovate drug discovery

The partnership will allow Canada’s CRO to leverage cutting-edge technology provided by the European HealthTech company, in order to innovate and optimize preclinical studies

Emmes Supports New Collaboration to Accelerate COVID-19 Research for Children